| Followers | 152 |
| Posts | 4903 |
| Boards Moderated | 0 |
| Alias Born | 11/03/2016 |
Wednesday, October 27, 2021 11:44:48 AM
Toxicity. That’s why they got the patent so cheap. Also check how they failed a few times in how they ( sbfm) tried to “package” the patent to sell to themselves through various corporate structure.
It’s ALL THERE.... and when this totally collapses the sad thing is there will be people saying it was an “outside” conspiracy against the company rather then a conspiracy BY the company.
If you research the various corporate structures and LLC’s involved it’s all there.
Ok. Bye.
It’s ALL THERE.... and when this totally collapses the sad thing is there will be people saying it was an “outside” conspiracy against the company rather then a conspiracy BY the company.
If you research the various corporate structures and LLC’s involved it’s all there.
Ok. Bye.
Recent SBFM News
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
